Bristol-Myers Squibb and Alvin Ailey American Dance Theater Announce First-of-Its-Kind Collaboration

Bristol-Myers SquibbBristol-Myers Squibb Company (NYSE: BMY) and Alvin Ailey American Dance Theater announced the launch of the 2011 REYATAZ® (atazanavir sulfate) "Fight HIV Your Way" contest. The contest aims to help raise awareness about HIV/AIDS among the general public and inspire people impacted by the disease to continue their fight.

Now in its third year, the 2011 REYATAZ "Fight HIV Your Way" contest breaks new ground, incorporating the power of dance to celebrate the inspiring stories of selected individuals across the country who are fighting HIV their way. Beginning December 1, 2010 through February 28, 2011, individuals touched by HIV and AIDS are invited to share their stories - as a photo and essay - through www.fightHIVyourway.com or mail in their entries*. Bristol-Myers Squibb will announce the ten first place winners in July 2011. These winning entries will be the inspiration for a new dance by Alvin Ailey American Dance Theater, created by a renowned choreographer selected by Artistic Director Designate Robert Battle. The work will have its world premiere during Ailey's New York City Center season in December 2011 and be performed across the country as part of a 2012 national tour.

Despite HIV/AIDS education efforts, there are still more than one million people with HIV in the U.S.(1) and the most recent data from 2006 indicate that approximately 56,300 new infections occur each year in the U.S. alone.(2) The REYATAZ "Fight HIV Your Way" contest leverages the power of words and visual arts as a platform to raise public awareness and lessen the stigma surrounding HIV/AIDS.

"Today, as we open Ailey's New York season celebrating 50 years of Alvin Ailey's inspiring Revelations and announce the launch of the REYATAZ "Fight HIV Your Way" contest, the poignancy of this date couldn't be stronger: we lost our founder, Alvin Ailey, to the disease 21 years ago on December 1st, 1989," shared Artistic Director Judith Jamison. "Alvin Ailey American Dance Theater is proud to be paying homage to the thousands of individuals fighting HIV their way and look forward to unveiling this original collaboration next year."

"Bristol-Myers Squibb and the Alvin Ailey American Dance Theater both have longstanding commitments to supporting the fight against HIV and AIDS. We are honored to collaborate with Ms. Jamison and The Ailey Organization, coming together and helping to continue dialogue about this disease," said Raymond Sacchetti, senior vice president, U.S. Virology, Bristol-Myers Squibb. "The 2011 extension and evolution of the REYATAZ "Fight HIV Your Way" contest exemplifies Bristol-Myers Squibb's ongoing commitment to increasing public awareness for people with HIV/AIDS."

An expert panel of judges will evaluate the contest entries based on the impact of the photographs' and essays' visual and verbal expression of the fight against HIV, creativity, originality and overall artistic quality.

"Dance is a transformational visual art that has the unique power to unite diverse audiences," said original Broadway Dreamgirl Sheryl Lee Ralph, a spokesperson for the National Minority AIDS Council and creator and producer of the HIV-inspired, award-winning Broadway shows Divas Simply Singing! and Sometimes I Cry. "Bristol-Myers Squibb's REYATAZ "Fight HIV Your Way" contest provides people with a channel to express how they fight HIV their way. This year, with the Alvin Ailey American Dance Theater's involvement, the photos and essays will, literally, move - and continue to provide courage and strength for others with HIV."

For more information on the 2011 REYATAZ® (atazanavir sulfate) "Fight HIV Your Way" contest, including official rules and guidelines, and entry forms please visit www.fightHIVyourway.com.

About the Alvin Ailey American Dance Theater
Alvin Ailey American Dance Theater, recognized by U.S. Congressional resolution as a vital American "Cultural Ambassador to the World", grew from a now fabled 1958 New York performance that changed American dance. Now led by Judith Jamison, joined by artistic director designate Robert Battle, the Company has performed for an estimated 23 million people in 71 countries on 6 continents, including two historic residencies in South Africa, celebrating the African-American cultural experience and the American modern dance tradition. The Ailey Organization also includes; Ailey II (1974), a second company of young dancers and choreographers; The Ailey School (1969), extensive dance training programs; Ailey Arts In Education & Community Programs, bringing dance into classrooms and communities; and The Ailey Extension, dance and fitness classes for the general public at Ailey's home - The Joan Weill Center for Dance in New York City - the nation's largest building for dance. For more information, visit www.alvinailey.org.

About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit http://www.bms.com.

* Entries can be submitted via the form on www.FightHIVYourWay.com or can be mailed to "2011 HIV Photo Contest", Dept. 7372, PO Box 5010, Stacy, MN 55079-5010. Entries must be received by February 28, 2011.

1. Centers for Disease Control and Prevention, HIV in the United States, Fact Sheet. Accessed October 19, 2010. Available at: http://www.cdc.gov/hiv/resources/factsheets/PDF/us.pdf
2. Centers for Disease Control and Prevention, HIV Incidence. Accessed October 19, 2010. Available at http://www.cdc.gov/hiv/topics/surveillance/incidence.htm.

Most Popular Now

Fasenra (benralizumab) receives US FDA approval fo…

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab)...

A great place to do great things: Developing game-…

Science has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world. For the 14th year, the journal Science today recognized...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Scientists find where HIV 'hides' to evade detecti…

In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memor...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

New tissue-engineered blood vessel replacements on…

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doe...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

China's out of control 'silent killer' affects one…

More than one-third of adults in China have high blood pressure - often dubbed the "silent killer" for its lack of symptoms - but only about one in 20 have the condition ...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]